ViiV Healthcare
ViiV Healthcare is a specialist HIV company majority owned by GSK with Pfizer and Shionogi as shareholders. It develops and commercializes prevention and treatment medicines.
The Company
ViiV Healthcare is a specialist HIV company majority owned by GSK with Pfizer and Shionogi as shareholders. It develops and commercializes prevention and treatment medicines.
The company is driven by long-acting HIV therapies, market access, patents, and clinical evidence. The displayed figure is a market-watch estimate, not a current public financing value.
Why It Matters
The company is driven by long-acting HIV therapies, market access, patents, and clinical evidence. The displayed figure is a market-watch estimate, not a current public financing value.
Valuation History
- $18.2B→Jan 2026Shionogi buys Pfizer's 11.7% for $2.125BSource ↗
What Changed
Earlier public financing or market context recorded.
Latest profile review: Not independently disclosed.
THE NEXT COMPANY. A CLEARER PICTURE.
Get the next breakdown.
Independent company research and perspectives on private markets, delivered through The Private Ledger on Substack.